London, England - I had a very unique opportunity this week to join a group of entrepreneurs, chefs, scientists, advocates, writers, policymakers (including the very inspiring President of Mauritius, Ameenah Gurib), and other food and agriculture experts to attend a luncheon at Clarence House in London, England, with His Royal Highness The Prince of Wales, who serves as the Patron of the Crop Trust.

Holtville, California - Holtville Athletic Club Annual Rib Cook-Off Extravaganza

  • Samaha Park - Holtville, California  92250
  • Saturday, January 27, 2018 - 10:00am PST – Till all the ribs are gone approximately 2:00pm
  • Teams: (By Invitation)
  • Admission: Free

San Diego, California - During an all-hands employee meeting at the San Diego Zoo Friday, philanthropist T. Denny Sanford announced that he is making a $30 million donation—the largest single gift the San Diego Zoo has ever received. This generous gift will go toward the estimated $69 million cost of constructing a brand-new, completely reimagined children’s zoo, to be named The Sanford Children’s Zoo.

Washington, DC - The U.S. Food and Drug Administration announced Thursday that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information for adult use – including an expanded Boxed Warning, the FDA’s most prominent warning ‒ notifying about the risks of misuse, abuse, addiction, overdose and death, and slowed or difficult breathing that can result from exposure to codeine or hydrocodone.

Washington, DC - The U.S. Food and Drug Administration Friday expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test, called the BRACAnalysis CDx.

Washington, DC - The United States is deeply disappointed by Wednesday’s court decision in Burma to allow prosecution of Reuters reporters Wa Lone and Kyaw Soe Oo under the Official Secrets Act.